Qué financiamos (solo en inglés)

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

GAP5 Testicular Cancer Translational Research Project - DEN

Movember Funding to Date

Global funding AUD equivalent 1,200,000

What we seek to achieve

The aim of the project is to better understand the biology of relapse in testicular cancer. Research undertaken in this project will help build knowledge around why some men with early stage disease relapse after treatment and others don't.

Country
Denmark
Implemented by
Movember
Project start date
September 2015
Project Status
Completed July 2016

About the project

This project brings together a global team to collaborate, share knowledge and design a study aimed at understanding why current treatments are highly effective for many men with testicular cancer but not for others.

The goal is to identify what makes some men with testicular cancer resistant to chemotherapy and identify better ways to treat them in the first instance.


​Given that chemotherapy resistance is quite rare, a global effort was required to identify a large cohort of patients for this study. Researchers in this collaboration span six countries and have managed to identify and collect samples and clinical data from over 100 chemotherapy resistant patients. 

Through this project, the team aim to improve the ways in which men presenting with testicular cancer are treated to give them the best chance at beating the disease and improving their long term survival and quality of life. 

>
Page 1 of 33